Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-15-032063
Filing Date
2015-05-18
Accepted
2015-05-18 17:12:32
Documents
7
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A v410919_10qa.htm 10-Q/A 19918
  Complete submission text file 0001144204-15-032063.txt   4923414

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT eyeg-20150331.xml EX-101.INS 711810
3 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20150331.xsd EX-101.SCH 41135
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20150331_cal.xml EX-101.CAL 36570
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20150331_def.xml EX-101.DEF 264369
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20150331_lab.xml EX-101.LAB 326407
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20150331_pre.xml EX-101.PRE 321621
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36672 | Film No.: 15874062
SIC: 2834 Pharmaceutical Preparations